LEADER 02989nam  2200589Ia 450 
001 9910807023803321
005 20200520144314.0
010   $a6612601019
010   $a1-282-60101-6
010   $a9786612601019
010   $a1-60750-525-8
035   $a(CKB)2550000000012857
035   $a(EBL)501461
035   $a(OCoLC)620959900
035   $a(SSID)ssj0000430049
035   $a(PQKBManifestationID)11271462
035   $a(PQKBTitleCode)TC0000430049
035   $a(PQKBWorkID)10468012
035   $a(PQKB)11268597
035   $a(MiAaPQ)EBC501461
035   $a(Au-PeEL)EBL501461
035   $a(CaPaEBR)ebr10375709
035   $a(CaONFJC)MIL260101
035   $a(EXLCZ)992550000000012857
100   $a20100401d2010      uy         0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aTravel medicine $eknowledge, attitude, practice and immunisation /$fAnna Helena Elvire Roukens
205   $a1st ed.
210   $aAmsterdam $cIOS Press$dc2010
215   $a1 online resource (200 p.)
300   $aDescription based upon print version of record.
311   $a1-60750-483-9 
327   $aTitle page; Contents; Chapter outline; General introduction; Performance of self-diagnosis and standby treatment of malaria in international oilfield service employees in the field; Health preparations and travel-related morbidity of kidney transplant recipients travelling to developing countries; Symptoms of infectious diseases in travelers with diabetes: a prospective study with matched controls; Yellow fever vaccination of the elderly: the humoral immune response lagging behind; Intradermal Hepatitis B vaccination in non-responders after topical application of imiquimod (Aldaraź)
327   $aIntradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomised controlled non-inferiority trial Reduced intradermal test dose of yellow fever vaccine induces protective immunity in individuals with egg allergy; Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a Purified Chicken Embryo Cell Vaccine (PCECV) is immunogenic and safe in adults; Summary and discussion; Nederlandse samenvatting; Abbreviations; Publications; Curriculum vitae
330   $aAddresses the subject of travel medicine and improving protection, with regard particularly to the areas of epidemiology and prevention, morbidity and mortality, adherence to precautions, immunological responsivity and the availability of preventive measures.
606   $aTravelers$xDiseases
606   $aTravel$xHealth aspects
615  0$aTravelers$xDiseases.
615  0$aTravel$xHealth aspects.
676   $a616.9802
700   $aRoukens$b Anna Helena Elvire$01666185
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910807023803321
996   $aTravel medicine$94025311
997   $aUNINA